{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:29:19Z","timestamp":1780655359514,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000014","name":"Canadian Blood Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jtct.2022.03.029","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T06:57:03Z","timestamp":1649401023000},"page":"408.e1-408.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure"],"prefix":"10.1016","volume":"28","author":[{"given":"Jasmine","family":"Candeliere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6432-3018","authenticated-orcid":false,"given":"Aidan M.","family":"Kirkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2302-6145","authenticated-orcid":false,"given":"Philip","family":"Berardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Seftel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3261-8289","authenticated-orcid":false,"given":"David S.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.03.029_bib0001","series-title":"StatPearls","article-title":"Hematopoietic stem cell transplantation","author":"Khaddour","year":"2021"},{"key":"10.1016\/j.jtct.2022.03.029_bib0002","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bmt.1704430","article-title":"Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals","volume":"33","author":"Kiss","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0003","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/j.bbmt.2020.02.022","article-title":"Clonal hematopoiesis in related allogeneic transplant donors: implications for screening and management","volume":"26","author":"Seftel","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0004","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbmt.2010.10.010","article-title":"Donor cell leukemia: a review","volume":"17","author":"Wiseman","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1704588","article-title":"Transmission of donor illness by stem cell transplantation: should screening be different in older donors?","volume":"34","author":"Niederwieser","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13073-019-0664-4","article-title":"Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants","volume":"11","author":"He","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.jtct.2022.03.029_bib0007","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for Scoping Reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2022.03.029_bib0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0009","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/s41409-021-01214-z","article-title":"Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome","volume":"56","author":"Williams","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0010","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.bbmt.2018.01.033","article-title":"Donor cell-derived hematologic neoplasms after hematopoietic stem cell transplantation: a systematic review","volume":"24","author":"Su\u00e1rez-Gonz\u00e1lez","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0011","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/leu.2016.23","article-title":"Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation","volume":"30","author":"Kato","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.03.029_bib0012","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/bmt.2017.226","article-title":"Donor cell-derived transient abnormal myelopoiesis as a specific complication of umbilical cord blood transplantation","volume":"53","author":"Hiramoto","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0013","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ejh.13498","article-title":"Donor stem cell-derived paroxysmal nocturnal hemoglobinuria after umbilical cord blood transplantation","volume":"105","author":"Nakaya","year":"2020","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1182\/blood-2017-01-764951","article-title":"Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias","volume":"130","author":"Gibson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.03.029_bib0015","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.bbmt.2017.05.013","article-title":"Acquired complement regulatory gene mutations and hematopoietic stem cell transplant-related thrombotic microangiopathy","volume":"23","author":"Ardissino","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.604547","article-title":"Case report: calpainopathy presenting after bone marrow transplantation, with studies of donor genetic content in various tissue types","volume":"11","author":"Martens","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0017","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1080\/10428194.2018.1553301","article-title":"A unique case of donor cell myeloma","volume":"60","author":"Ruiz-Arg\u00fcelles","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.03.029_bib0018","article-title":"Donor-derived smoldering multiple myeloma following a hematopoietic cell transplantation for AML","volume":"2017","author":"Fakhri","year":"2017","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0019","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jcp.2010.084731","article-title":"Donor cell origin of multiple myeloma occurring after allogeneic haematopoietic stem cell transplantation in a patient with refractory anaemia with ring sideroblast","volume":"64","author":"Kim","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0020","article-title":"54-year-old woman with donor cell origin of multiple myeloma after allogeneic hematopoietic stem cell transplantation for the treatment of CML","volume":"2016","author":"Maestas","year":"2016","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0021","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-11-0208","article-title":"Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation","volume":"2","author":"Weigert","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtct.2022.03.029_bib0022","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/08880019809014019","article-title":"Epstein-Barr virus-associated lymphoproliferative disorder after unrelated bone marrow transplantation in a young child with Wiskott-Aldrich syndrome","volume":"15","author":"Sasahara","year":"1998","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0023","first-page":"708","article-title":"Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization","volume":"122","author":"Lones","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtct.2022.03.029_bib0024","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood.V71.5.1234.1234","article-title":"Epstein-Barr virus-associated B cell lymphoproliferative disorders following bone marrow transplantation","volume":"71","author":"Shapiro","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.03.029_bib0025","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1056\/NEJMc0807172","article-title":"Osteosarcoma derived from donor stem cells carrying the Norrie's disease gene","volume":"359","author":"Berger","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.03.029_bib0026","article-title":"Donor cell myeloid sarcoma in an umbilical cord transplant patient: a case report and a review of the literature","volume":"2015","author":"Hayes","year":"2015","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0027","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1309\/UAR9WVFH4AGHM5ME","article-title":"Flow cytometric detection of nonneoplastic antigenic polymorphisms of donor origin after allogeneic marrow transplant: a report of two cases","volume":"122","author":"Wang","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3892\/or.2017.5703","article-title":"Genetic testing and counseling of a recipient after bone marrow transplant from a sibling harboring a germline BRCA1 pathogenic mutation","volume":"38","author":"\u0160kerl","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jtct.2022.03.029_bib0029","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1532\/IJH97.06162","article-title":"Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"86","author":"Mitsui","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cancergencyto.2009.01.001","article-title":"Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation","volume":"190","author":"Erdag","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jtct.2022.03.029_bib0031","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/bmt.2015.168","article-title":"Donor-derived constitutional chromosomal abnormalities after allogeneic hematopoietic cell transplantation: a single-center experience and a review of the literature","volume":"50","author":"Nishihori","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0032","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00320894","article-title":"Transplantation of bone marrow with constitutional chromosomal anomalies. Cytogenetic studies and clinical implications","volume":"53","author":"Becher","year":"1986","journal-title":"Blut"},{"key":"10.1016\/j.jtct.2022.03.029_bib0033","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/01.mph.0000152570.68318.84","article-title":"Stem cells carrying abnormal karyotype engraft after cord blood stem cell transplant","volume":"27","author":"Moore","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0034","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/2193-1801-3-72","article-title":"Donor-derived 47, XXY in an unrelated cord blood transplant recipient","volume":"3","author":"Kawaguchi","year":"2014","journal-title":"Springerplus"},{"key":"10.1016\/j.jtct.2022.03.029_bib0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/sj.bmt.1702182","article-title":"Diagnosis of Klinefelter syndrome in the donor after peripheral blood stem cell transplantation","volume":"25","author":"Ha\u0142aburda","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0036","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1532\/IJH97.A20705","article-title":"Successful bone marrow transplantation for treatment of chronic myeloid leukemia from a donor with mosaic Klinefelter syndrome","volume":"86","author":"Ismail","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0037","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1080\/10428194.2020.1750609","article-title":"Significance of isolated deletion (20q) in donor cells after allogeneic hematopoietic cell transplantation","volume":"61","author":"Nathan","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.03.029_bib0038","doi-asserted-by":"crossref","first-page":"e22951","DOI":"10.1002\/jcla.22951","article-title":"Clonal dominance of a donor-derived del(20q) clone after allogeneic hematopoietic stem cell transplantation in an acute myeloid leukemia patient with del(20q)","volume":"33","author":"Yoon","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jtct.2022.03.029_bib0039","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cancergen.2015.10.003","article-title":"Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm","volume":"208","author":"Aikawa","year":"2015","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jtct.2022.03.029_bib0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12308-011-0123-7","article-title":"Donor-derived isolated del(20q) after hematopoietic stem cell transplantation: report of two cases and review of the literature","volume":"6","author":"Kanagal-Shamanna","year":"2013","journal-title":"J Hematopathol."},{"key":"10.1016\/j.jtct.2022.03.029_bib0041","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.bbmt.2017.05.019","article-title":"Inversion 3 cytogenetic abnormality in an allogeneic hematopoietic cell transplant recipient representative of a donor-derived constitutional abnormality","volume":"23","author":"Dias","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0042","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2141.2002.3242_3.x","article-title":"Allogenic marrow grafts from unrelated donors with congenital pericentric inversion of chromosome 9","volume":"116","author":"Keung","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0043","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.bmt.1704450","article-title":"Chromosomal transformation in donor cells following allogeneic bone marrow transplantation","volume":"33","author":"Lang","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-4608(95)00170-0","article-title":"Predominant 45,X,\u2013Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis","volume":"86","author":"Abeliovich","year":"1996","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.jtct.2022.03.029_bib0045","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/bmt.2010.296","article-title":"Inadvertent transplantation of haematopoietic stem cells carrying constitutional Robertsonian translocation from an apparently normal donor to an AML patient: a case report","volume":"46","author":"Consoli","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0046","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/sj.bmt.1704039","article-title":"Concurrent presence of both patient and donor t(14;18) in a follicular lymphoma patient after undergoing allogeneic BMT: implications for minimal residual disease detection post-transplant","volume":"31","author":"Rosenblum","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.029_bib0047","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ajh.21268","article-title":"Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor-derived constitutional abnormality","volume":"83","author":"Frey","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2022.03.029_bib0048","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/10428190410001670637","article-title":"Detection of trisomy 8 in donor-derived Ph- cells in a patient with Ph+ chronic myeloid leukemia successfully treated with Imatinib (STI571) in relapse after allogeneic transplantation","volume":"45","author":"Agis","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.03.029_bib0049","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1097\/TP.0000000000002861","article-title":"Donor-derived XYY after BMT from a healthy volunteer","volume":"103","author":"Imataki","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.03.029_bib0050","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.transci.2016.04.011","article-title":"Defining the genetics of thrombotic microangiopathies","volume":"54","author":"Vieira-Martins","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jtct.2022.03.029_bib0051","unstructured":"Canada Panel on Research Ethics. How to address material incidental findings. Available at: https:\/\/ethics.gc.ca\/eng\/incidental_findings.html. Accessed January 18, 2022)"},{"key":"10.1016\/j.jtct.2022.03.029_bib0052","doi-asserted-by":"crossref","first-page":"29","DOI":"10.21037\/sci.2018.09.02","article-title":"Reversing pathological remodeling of the bone marrow microenvironment in acute myeloid leukemia","volume":"5","author":"Allan","year":"2018","journal-title":"Stem Cell Investig"},{"key":"10.1016\/j.jtct.2022.03.029_bib0053","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2017.11.006","article-title":"Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML","volume":"22","author":"Duarte","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jtct.2022.03.029_bib0054","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.leukres.2017.12.004","article-title":"3q26\/EVI1 rearrangement in myelodysplastic\/myeloproliferative neoplasms: an early event associated with a poor prognosis","volume":"65","author":"Hu","year":"2018","journal-title":"Leuk Res"},{"key":"10.1016\/j.jtct.2022.03.029_bib0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jlme.12298","article-title":"Disclosing secondary findings from pediatric sequencing to families: considering the \"benefit to families\"","volume":"43","author":"Wilfond","year":"2015","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.jtct.2022.03.029_bib0056","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-020-02114-w","article-title":"Mosaic loss of human Y chromosome: what, how and why","volume":"139","author":"Guo","year":"2020","journal-title":"Hum Genet"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722011915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722011915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T23:47:32Z","timestamp":1726444052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722011915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2666636722011915"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.03.029","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}